Trial Summary
What is the purpose of this trial?
Mutual exclusivity is a word learning constraint in which the learner assumes that a given word refers to only one category of objects. In spoken languages, mutual exclusivity has been demonstrated in monolingual children as young as 17 months and cross-linguistically, while multilingual learners show an attenuated mutual exclusivity bias. Mutual exclusivity has not been robustly demonstrated in deaf children acquiring American Sign Language (ASL). Further, it is unclear if mutual exclusivity applies to those learning both a signed and a spoken language. Like unimodal bilinguals, bimodal bilingual (BiBi) children learn two words for an object, but these words are separated by modality. A BiBi child could therefore assume that all objects have two words (like unimodal bilinguals) or that all objects have one spoken word and one sign (within-modality mutual exclusivity). The goals of the current study are to demonstrate mutual exclusivity in monolingual deaf children acquiring ASL, and to determine if BiBi deaf children utilize mutual exclusivity within each modality.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment input cue for word learning in deaf children?
Research shows that using visual cues, like eye-tracking, can help improve reading skills in deaf children by enhancing their understanding of how letters and sounds relate. This approach has been effective in helping a deaf child transition from a basic reading strategy to reading more like typical readers.12345
Is eye-tracking for word learning in deaf children safe?
How does the eye-tracking treatment for word learning in deaf children differ from other treatments?
Research Team
Amy Lieberman, PhD
Principal Investigator
Boston University
Eligibility Criteria
This trial is for deaf children aged 18-60 months who were born with severe to profound hearing loss. It's suitable for those who use American Sign Language (ASL) and have normal or corrected-to-normal vision, regardless of whether their parents are deaf or hearing.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Experimental Procedure
Participants engage in structured word learning tasks involving object selection based on referential cues and mutual exclusivity
Follow-up
Participants are monitored for any additional insights or data collection post-experiment
Treatment Details
Interventions
- input cue (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University Charles River Campus
Lead Sponsor